Scientists create human embryonic stem cells with enhanced pluripotency

May 03, 2010

Whitehead Institute researchers have converted established human induced pluripotent stem (iPS) cells and human embryonic stem (ES) cells to a base state of greater pluripotency.

"This is a previously unknown pluripotent state in ," says Jacob Hanna, a postdoctoral researcher in the lab of Whitehead Member Rudolf Jaenisch. "It's the first time these cell types have approached the flexibility found in mouse ES cells."

ES cells and iPS cells have attracted much attention because of their potential to mature into virtually any cell type in the body. Because ethical and legal issues have hampered human ES cell research, mouse cells have provided a more viable platform for ES cell studies. However, mouse and human ES cells differ in a number of significant ways, raising the very real possibility that breakthroughs in mouse stem cell science simply won't be reproducible with human .

Researchers have had a relatively easy time genetically manipulating and preventing differentiation (maturation beyond the base pluripotent state) in mouse ES and iPS cells. But human ES and iPS cells have different sets of expressed and depend on different signaling pathways for growth and differentiation than mouse ES and iPS cells, which makes the human cells more difficult to work with.

Because of these biological differences, researchers refer to mouse ES and iPS cells as "naďve" while human ES and iPS cells, which teeter on the verge of maturation, are more mature and are referred to as being "primed" for differentiation.

Hanna thought this "primed" state of human cells might be attributable to the way the human ES cell lines are created and stored. To generate ES cell lines, researchers remove cells from an early-stage embryo, called a blastocyst. Once removed from this ball of 80-100 cells, the ES cells are put into serum with other cells to keep the ES cells alive and prevent them from differentiating.

In creating iPS cells, researchers take cells from an adult and insert three to four genes into the cells' genome. These genes reprogram the adult cells to an embryonic stem-cell-like state. Like ES cells, iPS cells are maintained in serum with other cells. Although human and mouse ES and iPS cells are created and handled in identical fashion, human cells inevitably default to the primed state, suggesting that perhaps some step in the process allows the human ES cells to move ever so slightly toward differentiation.

To determine whether ES and iPS cells could be made with traits similar to the analogous mouse cells, Hanna inserted two of the genes used to create iPS cells into established human ES and iPS cell lines. He also added growth factors into the cells' serum. After about three weeks, the human cells became like their mouse counterparts, both morphologically and biochemically.

"That was really exciting," says Jaenisch, who is also a professor of biology at MIT. "But the process required those inserted genes to be expressed, and that is not what he wanted. He wanted to do this without gene insertion."

Because the random insertion of genes can cause neighboring genes to be over- or under-expressed, potentially resulting in cancer or cell death, Hanna screened through hundreds of small molecules for candidates might mimic the function of the inserted genes. Finally, he found a cocktail of four molecules that converts established human ES and iPS cells to the naďve state characteristic of mouse ES cells.

Despite this discovery, we still know very little about human ES cells in this naďve state.

"I think this really opens things up, and gives us the possibility to define the biological properties of these new cells," says Jaenisch. "For example, we can to study whether gene targeting, which is highly efficient in mouse ES cells but exceedingly inefficient in traditional human ES cells, is improved in the new "naďve" human ES cells."

Not only is this line of research important for stem cell scientists, but it may also impact how human ES and iPS cells could be used therapeutically.

"Because the all of the differences between human ES cells and mouse ES cells, it's really important we understand what could be the basis of these differences before we really start proceeding into therapeutic application," says Hanna. "We want to really understand the biology of these cells and need to revisit a lot of the biology and differentiation potential of human ES and iPS cells."

Explore further: New way to sort cells without limitations of traditional methods

More information: "Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs" PNAS, May 3, 2010.

Related Stories

Human ES cells progress slowly in myelin's direction

Apr 09, 2009

Scientists from the University of Wisconsin, USA, report in the journal Development the successful generation from human embryonic stem cells of a type of cell that can make myelin, a finding that opens up new possibilities for bo ...

Unpacking condensins' function in embryonic stem cells

Feb 22, 2010

Regulatory proteins common to all eukaryotic cells can have additional, unique functions in embryonic stem (ES) cells, according to a study in the February 22 issue of the Journal of Cell Biology. If cancer ...

Recommended for you

Deciphering the origins of cell behavior

10 hours ago

Researchers at the Mechanobiology Institute, National University of Singapore, have made significant advances in our understanding of cellular biology; providing evidence that the inherent 'handedness' of ...

Researchers clarify how DNA damage signaling works

13 hours ago

The DNA molecule is chemically unstable, giving rise to DNA lesions of various kinds. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. The ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.